...
首页> 外文期刊>Microporous and mesoporous materials: The offical journal of the International Zeolite Association >Influence of structural, textural and surface properties of mesostructured silica and aluminosilicate carriers on aminoglycoside uptake and in vitro delivery
【24h】

Influence of structural, textural and surface properties of mesostructured silica and aluminosilicate carriers on aminoglycoside uptake and in vitro delivery

机译:介孔结构二氧化硅和硅铝酸盐载体的结构,结构和表面性质对氨基糖苷摄取和体外递送的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This work assessed the influence of structural, textural and surface features of mesostructured silica and aluminosilicate carriers on aminoglycosides encapsulation and in vitro release. A series of pure and functionalized mesostructured silica, as well as aluminosilicates, which belong to MCM-41, MCM-48 and SBA-15 classes, and two aminoglycosides with related structure, amikacin and kanamycin as biologically-active molecules were employed in order to prepare drug delivery systems. No significant toxicity of studied mesoporous carriers on MEF cells after 72 h of continuous exposure to 100 mu g/mL nanoparticles was noticed. The mesostructured supports and amikacin- and kanamycin-based hybrid samples were characterized by small- and wide-angle XRD, FT-IR spectroscopy, thermogravimetric analysis, and N-2 sorption isotherms. The uptake values for all amikacin-based hybrids are higher than those for kanamycin counterparts. Moreover, the first antibiotic can be loaded on functionalized (with 3-aminopropyl or methyl groups) SBA-15-type materials, unlike the last drug. Amikacin loaded into the mesopores of AlSBA-15 and SBA-15 vehicles exhibited a slower delivery rate than from MCM-48 and functionalized SBA-15 materials. Different than amikacin-based hybrids, kanamycin loaded on aluminosilicates (AlMCM-41 and AlSBA-15) caused faster delivery, the highest value of drug cumulative release at 24 h being obtained for AlMCM-41 support. (C) 2014 Elsevier Inc. All rights reserved.
机译:这项工作评估了介孔结构的二氧化硅和硅铝酸盐载体的结构,结构和表面特征对氨基糖苷包封和体外释放的影响。为了制造一系列的纯的和功能化的介孔结构的二氧化硅以及铝硅酸盐,它们属于MCM-41,MCM-48和SBA-15类,并使用了两个具有相关结构的氨基糖苷类,阿米卡星和卡那霉素作为生物活性分子。准备药物输送系统。连续暴露于100μg / mL纳米颗粒72小时后,未观察到研究的介孔载体对MEF细胞产生明显的毒性。通过小角度和广角XRD,FT-IR光谱,热重分析和N-2吸附等温线对介孔结构的支持物以及基于阿米卡星和卡那霉素的混合样品进行了表征。所有基于丁胺卡那霉素的杂种的吸收值均高于卡那霉素对应物。此外,与最后一种药物不同,第一种抗生素可以负载在功能化的(具有3-氨丙基或甲基基团)SBA-15型材料上。装载到AlSBA-15和SBA-15载体的中孔中的丁胺卡那霉素的递送速率比MCM-48和功能化SBA-15材料的递送速率慢。与基于丁胺卡那霉素的杂种不同,负载在硅铝酸盐上的卡那霉素(AlMCM-41和AlSBA-15)引起更快的递送,AlMCM-41载体在24小时内获得了最高的药物累积释放值。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号